Porcine brain peptide mixture.
Cerebrolysin is a standardized mixture of low-molecular-weight peptides and amino acids produced by enzymatic hydrolysis of porcine brain proteins. Developed and widely used clinically in Europe and Asia for neurological indications. Supplied as research-grade material with 3rd-party HPLC verification and full Certificate of Analysis per lot.
Cerebrolysin is a standardized mixture of low-molecular-weight peptides and amino acids produced by enzymatic hydrolysis of porcine brain proteins. Developed and widely used clinically in Europe and Asia for neurological indications.
The preparation is described in published literature as providing multiple neurotrophic factor-like activities — mimicking BDNF, GDNF, NGF, and CNTF signaling pathways in cell culture and animal models. Specific active components have been difficult to identify definitively; the activity is attributed to the peptide fraction collectively.
Approved in Austria, Germany, Russia, China, South Korea, and many other countries for stroke recovery, dementia, and traumatic brain injury. Not FDA-approved in the United States. Extensive clinical research literature spanning decades.
The above summarizes published research literature. This is not medical advice, a protocol, or a recommendation for use. This compound is supplied for laboratory research only.
Cerebrolysin is a complex mixture, not a single defined compound.
The full structural data and release specifications are in the Compound Profile section above. Every lot ships with an independently verified Certificate of Analysis.
Each lot is independently verified by a 3rd-party analytical laboratory (STERIS Labs, Alcami Analytical, or equivalent) before release. Release specification is HPLC purity ≥ 99.5% (typical > 99.8%), mass spectrometry identity match within ±0.5 Da, water content < 5.0% Karl Fischer, and endotoxin < 0.25 EU/mL by LAL (USP <85>).
Look up the full COA for your lot at coa-lookup.html.
All compounds ship at ambient temperature in discreet, tamper-evident packaging. Lyophilized peptide powder is stable at room temperature for typical transit windows, which is why research-grade vendors ship this way. Tracked; signature not required.
Store unopened lyophilized product at 2–8°C protected from light. Once reconstituted, most peptides are stable at 2–8°C for approximately 28 days (compound-dependent).
Approved in Austria, Germany, Russia, China, South Korea, and many other countries for stroke recovery, dementia, and traumatic brain injury. Not FDA-approved in the United States. Extensive clinical research literature spanning decades.
All PeptideBros compounds are sold strictly as chemical reference materials for in-vitro laboratory research. They are not for human consumption.
HPLC-verified. Mass-spec confirmed. Ambient-stable transit. The paperwork other vendors hope you never ask for.